Jyong Biotech Ltd.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MENS | 8SJ.F | 002566.SZ | DNA | PHAR | ALGS | |
|---|---|---|---|---|---|---|
| Market cap | 132.29M | 1.84B | 2.03B | 784.51M | 881.90M | 31.35M |
| P/E (TTM) | — | — | 76.8 | — | 38.9 | — |
| Forward P/E | — | — | 6.8 | -4.0 | 69.2 | -1.0 |
| Price/book | -5.2 | 2.4 | 0.9 | 1.8 | 2.9 | 1.0 |
| Dividend yield | — | — | 1.32% | — | — | — |
| 1-year change | −95.65% | −37.59% | −27.32% | +3.10% | −15.24% | −29.30% |
| Today | −2.25% | +1.70% | +1.66% | +8.27% | −3.63% | +5.68% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All MENS news ›Jyong Biotech Showcases Botanical Drug Portfolio At BIO 2026 International Convention
Jyong Biotech Ltd. participated in the BIO International Convention , held in San Diego, California, from June 22 to June 25, 2026. Jyong Biotech once again exhibited at the Taiwan Pavilion. The... participated in the BIO International…
Jyong Biotech Ltd. Auditor Raises 'Going Concern' Doubt
Jyong Biotech Ltd. filed its 20-F on May 15, 2026 for the period ending Dec 31, 2025. In this report its auditor, WWC, P.C., gave an unqualified opinion expressing doubt that the company can continue... Biotechnology & Medical Research…
Jyong Biotech Ltd Updates Market Access Strategy for Innovative Botanical Drugs
Published on 04/28/2026 at 08:30 am EDT During the clinical trials ? a one-year medication period for Botreso (Phase III) and a two-year period for PCP (Phase II) ? no drug-related serious adverse events were observed, indicating excellent…
Jyong Biotech to Host Two-Day Investor Events in Silicon Valley and Irvine, California
Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics ... Jyong Biotech to Host Two-Day…
Jyong Biotech Announces Participation in StockFan Virtual Investor Non-Deal Roadshow
New Taipei City, Taiwan/San Francisco, CA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech... Jyong Biotech Announces Participation in StockFan Virtual Investor Non-Deal Roadshow New…
Jyong Biotech Announces Proposed Texas Facility to Support Potential Commercialization of Its Drug Candidates
Following an evaluation of factors including government policies, market conditions, workforce recruitment and logistics, Jyong Biotech has submitted a facility and operations plan to local government authorities in the State of Texas and…
Jyong Biotech Ltd (MENS) Stock Price, News, Earnings & Company Profile
Jyong Biotech Targets BPH/LUTS Market With Proposed U.S. Manufacturing Facility October 15, 2026 10:43 ET Jyong Biotech (MENS) plans to establish a pharmaceutical manufacturing facility and U.S. jyong biotech ltd (MENS) Jyong Biotech…
Jyong Biotech Eyes Texas Manufacturing Hub to Accelerate US Market Expansion
19 October 2026 | Monday | News Following an evaluation of factors including government policies, market conditions, workforce recruitment and logistics, Jyong Biotech has submitted a facility and operations plan to local government…
Taiwan's Jyong Biotech to establish new manufacturing facility and US operations centre in Texas
October 17, 2026 | Saturday | News Jyong Biotech, a Taiwan-based science-driven biotechnology company dedicated to the development and commercialisation of innovative plant-derived therapeutics, has announced that it plans to establish a…
Jyong Biotech Plans Potential Texas Manufacturing Facility and U.S. Operations Center
Jyong Biotech plans to establish a manufacturing facility in Texas to support U.S. operations and drug commercialization. Jyong Biotech plans to establish a new manufacturing facility and U.S. operations center in Texas to support its U.S.…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com8
- markets.businessinsider.com4
- globenewswire.com2
- stocktitan.net2
- biopharmaapac.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 22 articles, not a forecast.